breast cancer cells - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

NeoTX commences dosing in Phase Ib trial of naptumomab

breast cancer cells
The Phase Ib trial will investigate naptumomab plus Imfinzi for treating advanced or metastatic solid tumours. Credit: Dr. Cecil Fox, National Cancer Institute, National Institutes of Health.